Haemonetics Corp
HAE· NYSE
HAEHaemonetics Corp
Source filing unavailable
| Metric | Q4 2011 | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|---|
| Revenue | $186.67M | $170.03M | $169.10M |
| Net Income | $17.81M | $20.99M | $3.96M |
| EPS Diluted | $0.35 | $0.81 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
